EM, E., BS, S., ZS, H., & Jr, L. T. (2016). Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach. Experimental hematology, 44(3), 157. https://doi.org/10.1016/j.exphem.2015.12.011
Chicago Style (17th ed.) CitationEM, Epner, Saroya BS, Hasanali ZS, and Loughran TP Jr. "Combination Epigenetic and Immunotherapy Overcomes Resistance to Monoclonal Antibodies in Hematologic Malignancies: A New Therapeutic Approach." Experimental Hematology 44, no. 3 (2016): 157. https://doi.org/10.1016/j.exphem.2015.12.011.
MLA (9th ed.) CitationEM, Epner, et al. "Combination Epigenetic and Immunotherapy Overcomes Resistance to Monoclonal Antibodies in Hematologic Malignancies: A New Therapeutic Approach." Experimental Hematology, vol. 44, no. 3, 2016, p. 157, https://doi.org/10.1016/j.exphem.2015.12.011.